Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The A to I editing landscape in melanoma and its relation to clinical outcome.

RNA biology - 1 Jan 2022

Amweg Austeja, Tusup Marina, Cheng Phil, Picardi Ernesto, Dummer Reinhard, Levesque Mitchell P, French Lars E, Guenova Emmanuella, Läuchli Severin, Kundig Thomas, Mellett Mark, Pascolo Steve

Abstract excerpt

RNA editing refers to non-transient RNA modifications that occur after transcription and prior to translation by the ribosomes. RNA editing is more widespread in cancer cells than in non-transformed cells and is associated with tumorigenesis of various cancer tissues. However, RNA editing can also generate neo-antigens that expose tumour cells to host immunosurveillance. Global RNA editing in melanoma and its...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Melanoma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to RNA-Binding Proteins

Share to RNA Editing

Share to Ubiquitin-Protein Ligases

Source

Open in PubMed Open full text

Identifiers

PMID: 35993275
DOI: 10.1080/15476286.2022.2110390
PMCID: PMC9415457

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The A to I editing landscape in melanoma and its relation to clinical outcome.PMID 35993275Read ↗

RNA Editing Signatures Predict Response to Immunotherapies in Melanoma PatientsSemantic proximity Read ↗

Physio-pathological effects of m6A modification and its potential contribution to melanoma.Semantic proximity Read ↗

Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors.Semantic proximity Read ↗

RNA Editing Dynamically Rewrites the Cancer Code.Semantic proximity Read ↗

Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives.Semantic proximity Read ↗

Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential.Semantic proximity Read ↗

Pan-cancer investigation of C-to-U editing reveals its important role in cancer development and new targets for cancer treatmentSemantic proximity Read ↗

Principles governing A-to-I RNA editing in the breast cancer transcriptomeSemantic proximity Read ↗

A Notch for noncoding RNA in melanoma.Semantic proximity Read ↗

Systematically Characterizing A-to-I RNA Editing Neoantigens in CancerSemantic proximity Read ↗

Role of m6A modification in stromal and immune activation patterns together with response to ICI in melanomaSemantic proximity Read ↗

BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.